Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies
The purpose of this study is to attempt to obtain an on-treatment biopsy in participants with non-small cell lung cancer who are receiving standard treatment with a drug that targets the PD-1 or PD-L1 protein.
Non Small Cell Lung Cancer
DIAGNOSTIC_TEST: Pre-Treatment Biopsy|DIAGNOSTIC_TEST: On-Treatment Biopsy|DIAGNOSTIC_TEST: Biopsy at Disease Progression|DIAGNOSTIC_TEST: Peripheral Blood-Based Studies
Number of participants biopsied on-treatment and with newly diagnosed or recurrent PD-L1 advanced Non Small Cell Lung Cancer/NSCLC, 24 weeks
The purpose of this study is to attempt to obtain an on-treatment biopsy in participants with non-small cell lung cancer who are receiving standard treatment with a drug that targets the PD-1 or PD-L1 protein.